Karen Anbro Gammeltoft

Nirmatrelvir-resistant SARS-CoV-2 variants with high fitness in an infectious cell culture system

Yuyong Zhou, Karen Anbro Gammeltoft, Line A. Ryberg et al. · Science Advances · 2022 · 216 citations · Full text

Viral Polymerase Structure, Reverse Genetics, Resistance Monitoring +17

In vitro efficacy of artemisinin-based treatments against SARS-CoV-2

Yuyong Zhou, Kerry Gilmore, Santseharay Ramírez et al. · Scientific Reports · 2021 · 92 citations · Full text

Hepatitis C Virus Protease Inhibitors Show Differential Efficacy and Interactions with Remdesivir for Treatment of SARS-CoV-2 <i>In Vitro</i>

Karen Anbro Gammeltoft, Yuyong Zhou, Carlos R. Duarte Hernandez et al. · Antimicrobial Agents and Chemotherapy · 2021 · 44 citations · Full text

Nirmatrelvir Resistant SARS-CoV-2 Variants with High Fitness in Vitro

Yuyong Zhou, Karen Anbro Gammeltoft, Line A. Ryberg et al. · 2022 · 43 citations · Full text

Nirmatrelvir-mpro Binding, Health Sciences, Emerging Infectious Diseases +13

Efficacy of Ion-Channel Inhibitors Amantadine, Memantine and Rimantadine for the Treatment of SARS-CoV-2 In Vitro

Yuyong Zhou, Karen Anbro Gammeltoft, Andrea Galli et al. · Viruses · 2021 · 29 citations · Full text